Literature DB >> 21490547

Moisture-associated skin damage: overview and pathophysiology.

Mikel Gray1, Joyce M Black, Mona M Baharestani, Donna Z Bliss, Janice C Colwell, Margaret Goldberg, Karen L Kennedy-Evans, Susan Logan, Catherine R Ratliff.   

Abstract

Moisture-associated skin damage (MASD) is caused by prolonged exposure to various sources of moisture, including urine or stool, perspiration, wound exudate, mucus, saliva, and their contents. MASD is characterized by inflammation of the skin, occurring with or without erosion or secondary cutaneous infection. Multiple conditions may result in MASD; 4 of the most common forms are incontinence-associated dermatitis, intertriginous dermatitis, periwound moisture-associated dermatitis, and peristomal moisture-associated dermatitis. Although evidence is lacking, clinical experience suggests that MASD requires more than moisture alone. Instead, skin damage is attributable to multiple factors, including chemical irritants within the moisture source, its pH, mechanical factors such as friction, and associated microorganisms. To prevent MASD, clinicians need to be vigilant both in maintaining optimal skin conditions and in diagnosing and treating minor cases of MASD prior to progression and skin breakdown.

Entities:  

Mesh:

Year:  2011        PMID: 21490547     DOI: 10.1097/WON.0b013e318215f798

Source DB:  PubMed          Journal:  J Wound Ostomy Continence Nurs        ISSN: 1071-5754            Impact factor:   1.741


  20 in total

Review 1.  Dressings and Products in Pediatric Wound Care.

Authors:  Alice King; Judith J Stellar; Anne Blevins; Kara Noelle Shah
Journal:  Adv Wound Care (New Rochelle)       Date:  2014-04-01       Impact factor: 4.730

2.  Candida albicans colonisation, continence status and incontinence-associated dermatitis in the acute care setting: a pilot study.

Authors:  Jill L Campbell; Fiona M Coyer; Alison M Mudge; Ivan M Robertson; Sonya R Osborne
Journal:  Int Wound J       Date:  2016-08-01       Impact factor: 3.315

3.  A laboratory comparison between two liquid skin barrier products.

Authors:  Kevin Y Woo; Debashish Chakravarthy
Journal:  Int Wound J       Date:  2014-07-08       Impact factor: 3.315

4.  Incontinence-associated dermatitis in community-dwelling individuals with fecal incontinence.

Authors:  Kristi Rohwer; Donna Z Bliss; Kay Savik
Journal:  J Wound Ostomy Continence Nurs       Date:  2013 Mar-Apr       Impact factor: 1.741

5.  Incontinence-associated dermatitis: a cross-sectional prevalence study in the Australian acute care hospital setting.

Authors:  Jill L Campbell; Fiona M Coyer; Sonya R Osborne
Journal:  Int Wound J       Date:  2014-06-26       Impact factor: 3.315

6.  Exploration of pressure ulcer and related skin problems across the spectrum of health care settings in Ontario using administrative data.

Authors:  Kevin Y Woo; Kim Sears; Joan Almost; Rosemary Wilson; Marlo Whitehead; Elizabeth G VanDenKerkhof
Journal:  Int Wound J       Date:  2015-11-20       Impact factor: 3.315

7.  Clinical evaluation of a water-in-oil emulsion with protective and regenerative properties for the anogenital area.

Authors:  Volkmar Küppers; Michael Kemper; Christoph Abels
Journal:  Clin Cosmet Investig Dermatol       Date:  2015-11-04

8.  Incontinence-Associated Dermatitis, Characteristics and Relationship to Pressure Injury: A Multisite Epidemiologic Analysis.

Authors:  Mikel Gray; Karen K Giuliano
Journal:  J Wound Ostomy Continence Nurs       Date:  2018 Jan/Feb       Impact factor: 1.741

9.  Associations between skin barrier characteristics, skin conditions and health of aged nursing home residents: a multi-center prevalence and correlational study.

Authors:  Elisabeth Hahnel; Ulrike Blume-Peytavi; Carina Trojahn; Jan Kottner
Journal:  BMC Geriatr       Date:  2017-11-13       Impact factor: 3.921

10.  Skin Protectants Made of Curable Polymers: Effect of Application on Local Skin Temperature.

Authors:  Michael J Walt; Nancy Atwood; Stéphanie F Bernatchez; Bruce P Ekholm; Robert Asmus
Journal:  Adv Wound Care (New Rochelle)       Date:  2017-04-01       Impact factor: 4.730

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.